[ad_1]
A marijuana drug to treat certain types of seizures may be available on prescription in Georgia this fall.
The US Food and Drug Administration has approved the use of Epidiolex for two rare and severe childhood forms of epilepsy-epilepsy: Dravet Syndrome and Lennox-Gastaut Syndrome [19659003ItsactiveingredientisCannabidiolachemicalcomponentofthemarijuanaplantthatdoesnotproducethehighthatcomesfromTHC
"This is a great first step," said Chuck Hufstetler, State Representative, R-Rome. "This shows that the FDA finally recognizes that there is value in cannabis and that it will be easier to use it in other situations. "
Evan Ross, the Democrat running against Hufstetler in the November general election, has a young son with l & rsquo; He said that the two approved syndromes do not apply to his child, but that once a drug is on the market, it often begins to be prescribed for D & D. Other uses.
"It's great," Ross agreed. "It may not be in your family, but if someone has a sick child, he'll do it." no matter what in the world to make him sick. "
Marijuana is still listed on the federal list as an illegal drug from Schedule I it has no medical value and can not to be tra States that voted to legalize it.
The manufacturer of Epidiolex – GW Pharmaceuticals of Britain – says in a press release that he expects the US Drug Enforcement Administration to reclbadify cannabidiol as a drug on order from here October.
State doctors are allowed to prescribe low THC oil for various conditions, from epilepsy and terminal cancer to PTSD, through the disease Crohn's and Parkinson's disease. . But the generic drug can not be grown, sold or bought in the state.
Ross said that he heard that GW Pharmaceuticals' drug would cost about $ 2,500 a year compared to about $ 1,800 a year for oil. This is an expensive hit, especially when it may not be covered by insurance. And she bypbades another potential profit for Georgia, Ross says.
"Why should a British pharmaceutical company be able to charge a lot more for a product when we should develop it and distribute it here?" "Farmers in Northwestern Georgia may have another commercial crop. I would like Georgia to benefit financially.
State Representative, Katie Dempsey, R-Rome, part of the Working Group on Home Medical Cannabis, said this issue was still under study
. The complete manufacturing process is our challenge, "she said. "A pure offer is the stumbling block."
Hufstetler said the rescheduling of Epidiolex will open the door to more research on medical marijuana in Georgia, and he could support doing so in the state if conditions are good. The real answer is for the federal government to change the designation of marijuana to an Schedule II drug, "said Hufstetler." Except that, we must consider making it in Georgia. "
He has says it's maintaining its decision to help block efforts to legalize the importation of Colorado oil, where it's legal.Tests have shown a lack of purity standards, did it? he says, but the main reason is that it is still a Schedule I drug.
"The legislation was problematic because it forced people to break the law. "Pharmaceuticals plans to market Epidiolex through its US subsidiary Greenwich Biosciences." The company said trials are already underway on two other forms of epilepsy, the tuberous sclerosis complex and infantile spasms. [19659003] The drug is already used in other country to treat spasticity due to multiple sclerosis. , the GW Pharmaceuticals release says the company "has a deep pipeline on other cannabinoid products" for epilepsy, glioblastoma, cancer and schizophrenia.
[ad_2]
Source link
